Literature DB >> 915903

Improved delivery through biological membranes. 4. Prodrugs of L-dopa.

N Bodor, K B Sloan, T Higuchi, K Sasahara.   

Abstract

Various classes of transient derivatives of L-Dopa have been synthesized, systematically protecting one or more of the main sites of metabolism in the molecule: the carboxy function, the amino, and/or the catechol system. The derivatives studied include carboxy esters, phenol esters, amides, peptides, and various combinations of these functions. A number of these derivatives effectively prevent the metabolism of L-Dopa prior to and/or during the absorption process, resulting in a significantly better bioavailability of the drug. In vivo studies using dogs showed up to 2.5-fold increase in L-Dopa blood levels. The metabolism as well as toxicity aspects of the prodrugs is also discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915903     DOI: 10.1021/jm00221a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.

Authors:  H D Kao; A Traboulsi; S Itoh; L Dittert; A Hussain
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

Review 2.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

3.  Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.

Authors:  M Hu; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

Review 4.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

5.  Antisickling activity of amino acid benzyl esters.

Authors:  M Gorecki; C T Acquaye; M Wilchek; J R Votano; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.

Authors:  J P Bai
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

Review 7.  Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Authors:  Fatma Haddad; Maryam Sawalha; Yahya Khawaja; Anas Najjar; Rafik Karaman
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

8.  A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.

Authors:  Hiroo Yokozeki; Tomoko Fujimoto; Yoichiro Abe; Masaru Igarashi; Akiko Ishikoh; Tokuya Omi; Hiroki Kanda; Hiroto Kitahara; Miwako Kinoshita; Ichiro Nakasu; Naoko Hattori; Yuki Horiuchi; Ryuji Maruyama; Haruko Mizutani; Yoshiyuki Murakami; Chiharu Watanabe; Akihiro Kume; Takaaki Hanafusa; Masamitsu Hamaguchi; Akira Yoshioka; Yuriko Egami; Keizo Matsuo; Tomoko Matsuda; Motoki Akamatsu; Toshiyuki Yorozuya; Shinichi Takayama
Journal:  J Dermatol       Date:  2021-01-07       Impact factor: 4.005

Review 9.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.